I am a postdoctoral scientist working in the bioinformatic unit of the Prencancer group.

I am developing a method to use high throughput sequencing data (Illumina) to estimate Copy Number Alterations (CNA) in patients¹ tumour. In particular, we take advantage of the linearity between depth of coverage and CNA to estimate ploidy and tumour content in clinical samples. Such information will allow a better understanding of CNA in hundreds of clinical samples.